In this article
Maybe your ponytail feels thinner. Maybe your part looks wider in photos, or more hair collects in the shower drain than it used to. Hair changes are common around and after menopause, and they can be upsetting. The good news is that most hair thinning in midlife has a name, a pattern, and a known set of treatment options. This guide explains the two most common causes, what a clinician looks for, and what the research shows about treatment.
Why hair thins after menopause
Female pattern hair loss (also called female androgenetic alopecia) is the most common type of hair loss in women [4, 10]. A recent review estimates it affects nearly half of women during their lifetime [1]. Studies in different populations consistently find that it becomes more common with age [2].
Menopause seems to play a part. A 2025 systematic review of 40 studies found that female pattern hair loss and frontal fibrosing alopecia (a scarring type of hair loss) showed the strongest links to menopause among the skin conditions studied, with most cases appearing after menopause and earlier or surgical menopause carrying greater risk [3].
Why this happens is not fully understood. One idea is that falling estrogen leaves the body in a state of relative androgen dominance [2]. But studies have not found a clear link between testosterone levels in the blood and female pattern hair loss [2]. Researchers are also looking at insulin resistance, higher body weight, and metabolic syndrome as possible risk factors after menopause [2].
What happens at the follicle is clearer. In pattern hair loss, each growth phase gets shorter, and follicles gradually shrink, so thick hairs are replaced by finer, shorter ones [10]. This is called miniaturization. It is why the hair looks thinner even when you are not losing more strands than usual.
Pattern thinning vs shedding: two different problems
The second common cause is telogen effluvium, a temporary increase in shedding. Normally about 10% of scalp hairs are in the resting (telogen) phase at any one time [6]. After a shock to the system, many more hairs switch into that phase at once and then fall out together.
Triggers include illness, surgery, childbirth, nutritional deficiencies, medicines, and infection, though a cause cannot always be found [7]. MedlinePlus notes that physical or emotional stress may cause one half to three quarters of scalp hair to shed, and that you may not notice it for weeks to months after the event [5]. Shedding usually starts two to three months after the trigger [6].
| Female pattern hair loss | Telogen effluvium (shedding) | Frontal fibrosing alopecia | |
|---|---|---|---|
| What you notice | Gradual thinning on the top and crown, a widening part [4] | More hair falling out all over the scalp [6, 7] | The hairline slowly moves back, often with eyebrow loss [9] |
| Where it shows | Top and crown; front hairline usually kept [4] | All over the scalp (diffuse) [7] | Recedes as a smooth, scarred band [9] |
| What is happening | Follicles shrink over time [10] | Many hairs enter the resting phase at once [6] | Inflammation scars the follicles [9] |
| Course | Slowly progressive; untreated loss is usually permanent [4] | Acute cases usually settle [6, 7] | Slow and progressive [9] |
You can have more than one at once. A review of women with pattern hair loss lists chronic telogen effluvium, alopecia areata, and scarring alopecias among the conditions a clinician needs to rule out [1]. Acute telogen effluvium lasts less than six months; shedding that goes on longer is called chronic [6]. A review found that acute cases remit in about 95% of patients [6].
What a clinician checks
Diagnosis is mostly made by looking. Clinicians recognize pattern hair loss from the shape of the thinning and your medical history, while ruling out other causes such as thyroid disease or iron deficiency [4]. They may also look for signs of excess androgens [4].
- Your history. When it started, whether it came on suddenly, recent illness, surgery, weight loss, new medicines, and family history [5, 7].
- Your scalp. A close look with a magnifying scope (trichoscopy) and a gentle pull test, where the clinician tugs a small bunch of hair to see how much comes out [1].
- Blood tests. A 2026 clinical review lists thyroid-stimulating hormone (TSH), a complete blood count, and iron studies as recommended tests [8].
- A biopsy, rarely. A small scalp sample is mainly used to confirm a scarring type of hair loss [8].
Why thyroid and iron? Both an overactive and an underactive thyroid can cause telogen effluvium, and it resolves once thyroid levels are corrected [6]. Anemia is also a known cause of hair loss [5]. The link between low iron stores without anemia and shedding is less certain; one review describes it as very controversial [6]. Even so, iron tests are part of the usual workup [8].
Call your clinician soon if your hair is falling out quickly, comes out in patches, or comes with fatigue, weight gain, muscle weakness, or feeling cold all the time [5]. These can point to a cause that needs its own treatment.
What the treatment evidence shows
If the cause is shedding, treatment starts with finding and removing the trigger, and reassurance, because acute shedding usually settles on its own [7]. If the cause is pattern hair loss, treatment aims to slow thinning and regrow some hair. Here is what the research says about the main options.
Topical minoxidil: the best-studied option
A Cochrane review pooled 47 randomized trials of treatments for female pattern hair loss [10]. Across six trials, women using minoxidil were about twice as likely as those using a placebo to report moderate to marked regrowth (157 of 593 vs 77 of 555) [10]. Hair counts also rose more with minoxidil [10]. The reviewers found no clear difference between the 2% and 5% strengths [10].
Minoxidil is the only FDA-approved medicine for female pattern hair loss [1, 4]. MedlinePlus says it may help about 1 in 4 or 5 women grow hair and may slow or stop loss in most, but it has to be used long term, because hair loss returns after stopping [4]. Read more in our guide to minoxidil for women.
Finasteride: weaker evidence in women
Finasteride blocks the conversion of testosterone to the stronger androgen DHT. In a one-year trial of 137 postmenopausal women aged 41 to 60, finasteride 1 mg a day did not increase hair growth or slow thinning compared with placebo [11]. The Cochrane review rated the evidence that finasteride works better than placebo as low quality and found no benefit [10]. Topical finasteride is newer and less studied; see topical finasteride for women.
Other options
Clinicians also use off-label treatments, including low-dose oral minoxidil, spironolactone and other anti-androgens, and hair transplantation [1]. Low-level light and platelet-rich plasma are sometimes added to medical treatment [1]. In the Cochrane review, results for laser devices were inconsistent [10]. Reviewers point out that there are few randomized trials that include women, so many of these choices rest on limited evidence [1].
What about hormone therapy? A 2025 systematic review found the data on menopausal hormone therapy and hair loss limited and inconsistent, and it linked hormone therapy with a higher risk of frontal fibrosing alopecia [3]. Hormone therapy is not an established treatment for hair thinning, though your clinician will weigh it for your other symptoms.
Setting realistic expectations
Hair grows slowly, so every hair treatment takes time. The FDA-approved women's minoxidil foam label says results may appear at 3 months, and some women need at least 6 months of daily use before they see results [12]. It also says the amount of regrowth differs from person to person and that the product will not work for every woman [12].
- Take a clear photo of your part and crown in the same light before you start. Comparing photos months apart is easier than judging day to day.
- Expect the goal to be slower thinning and some regrowth, not a full return to the hair you had at 25 [4, 10].
- Keep going if it is working. Stopping minoxidil means the loss starts again [4, 12].
- Tell your clinician about any new medicine, illness, or big change in diet, since these can trigger shedding on top of pattern loss [7].
Hair treatment through WarriorBabe Health
WarriorBabe Health offers four prescription scalp sprays built on topical minoxidil, each combined with other ingredients. You can compare them on our hair treatments page, and we explain what each add-on ingredient is meant to do, and how much evidence there is, in minoxidil combination sprays.
- Minoxidil + Tretinoin Hair Spray: minoxidil, finasteride, and tretinoin.
- Minoxidil + Ketoconazole Hair Spray: minoxidil, finasteride, latanoprost, and ketoconazole.
- Minoxidil + Fluocinolone Hair Spray: minoxidil, tretinoin, fluocinolone, and finasteride.
- Minoxidil + Biotin Hair Spray: minoxidil, tretinoin, fluocinolone, biotin, and melatonin.
These sprays are compounded by a licensed pharmacy under your clinician's prescription. Compounded drugs are not FDA-approved, which means the FDA does not review their safety, effectiveness, or quality before they are marketed [13]. In plain terms: the FDA does not verify the safety, effectiveness, or quality of compounded drugs. The trials described above tested single ingredients, not these combinations.
Three of the four sprays contain finasteride, which must not be used if you are pregnant or could become pregnant. Your clinician will review your history, including your thyroid and iron results if you have them. To see whether a hair treatment might suit you, take the 2-minute quiz.
Frequently asked questions
Does menopause cause hair thinning?
Female pattern hair loss becomes more common with age, and a systematic review found its strongest links with menopause, with most cases appearing afterward and earlier or surgical menopause carrying more risk [2, 3]. Falling estrogen may play a role, but studies have not found a clear link with testosterone levels, so the cause is not fully understood [2].
How do I know if it's shedding or pattern hair loss?
Pattern hair loss is a slow thinning on the top and crown with a widening part, and the front hairline is usually kept [4]. Shedding (telogen effluvium) is more hair falling out all over, usually starting two to three months after a trigger such as illness or surgery [6, 7]. A clinician can tell them apart by examining your scalp, and you can have both [1].
What blood tests should I ask for?
A 2026 clinical review lists thyroid-stimulating hormone, a complete blood count, and iron studies as the recommended tests for hair loss [8]. Clinicians check these because thyroid disease and anemia can both cause hair loss [5, 6]. Your clinician may add other tests if you have signs of excess androgens [4].
Will my hair grow back after shedding?
Telogen effluvium is usually reversible, with gradual regrowth over time [7]. Acute shedding lasts less than six months, and a review found remission in about 95% of acute cases [6]. Shedding that lasts longer is called chronic and is worth reviewing with your clinician [6].
What is the most effective treatment for menopause hair thinning?
For female pattern hair loss, topical minoxidil has the strongest evidence. In a Cochrane review, women using it were about twice as likely as those using placebo to report moderate to marked regrowth [10]. It is the only FDA-approved medicine for this condition [1]. Oral finasteride did not help postmenopausal women in a one-year trial [11].
References
- Kearney CA, Brinks AL, Lawrence CN, et al. Androgenetic alopecia in women: a narrative review of pathophysiology, clinical evaluation, and treatments. Am J Clin Dermatol. 2026;27(2):363-389. pubmed.ncbi.nlm.nih.gov/41714473/
- Anderson A, Konopelski P, Skorzewska K, et al. The role of hormones in female androgenetic alopecia: focus on menopause. Climacteric. 2026. pubmed.ncbi.nlm.nih.gov/42755697/
- Roster K, Fleshner L, Karatas TB, et al. Menopause and common dermatoses: a systematic review. Am J Clin Dermatol. 2026;27(1):67-84. pubmed.ncbi.nlm.nih.gov/41331233/
- MedlinePlus Medical Encyclopedia. Female pattern baldness. US National Library of Medicine. Reviewed 1/28/2026. medlineplus.gov/ency/article/001173.htm
- MedlinePlus Medical Encyclopedia. Hair loss. US National Library of Medicine. Reviewed 6/3/2025. medlineplus.gov/ency/article/003246.htm
- Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R. Telogen effluvium: a review of the literature. Cureus. 2020;12(5):e8320. pmc.ncbi.nlm.nih.gov/articles/PMC7320655/
- Bergfeld WF, Mendez D. Shedding: an updated guide to a common cause of hair loss. Cleve Clin J Med. 2026;93(10):616-622. pubmed.ncbi.nlm.nih.gov/42823125/
- Walker CW, Champigny D, Hartman T, Hulsey B, Hoffart C. Hair loss: a systematic approach to evaluation, diagnosis, and management. JAAPA. 2026;39(9):27-34. pubmed.ncbi.nlm.nih.gov/42647672/
- Alenezi S, Ezzat RZ, Miteva M. Frontal fibrosing alopecia part I: diagnosis and clinical presentation. J Am Acad Dermatol. 2026;94(4):1059-1072. pubmed.ncbi.nlm.nih.gov/39824360/
- van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;(5):CD007628. pubmed.ncbi.nlm.nih.gov/27225981/
- Price VH, Roberts JL, Hordinsky M, et al. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. J Am Acad Dermatol. 2000;43(5 Pt 1):768-776. pubmed.ncbi.nlm.nih.gov/11050579/
- Women's Rogaine (minoxidil 5%) topical aerosol foam, Drug Facts label. DailyMed, US National Library of Medicine. Published 11/2024. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d328537-b7f5-43cc-9837-c5a0c6c390f8
- US Food and Drug Administration. Understanding the risks of compounded drugs. www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
This article is for general information. It is not medical advice and does not replace a visit with a licensed clinician who knows your history. Do not start, stop or change a medication without talking to your clinician. If you think you are having a medical emergency, call 911.







